ScholarIQanswers from OpenAlex
Insmed
FunderResearch funding and supported work
Insmed is a funder indexed in ScholarIQ from OpenAlex.
What is known about Insmed?
ScholarIQrecord summary
company in Bridgewater, United States
How many works does Insmed have?
ScholarIQindexed works
Insmed has 777 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Insmed?
ScholarIQopenalex
The OpenAlex for Insmed is on the source record.
What are the most-cited papers on Insmed?
ScholarIQmost cited works
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
Felix Carl Saalfeld, Johanna Möller, Petros Christopoulos, Carina Wenzel, Anna Rasokat, Xuefu Wang, Ioannis Vathiotis, David König, Oliver Illini, Christian Grohé, Marcel Wiesweg, Claas Wesseler, Christoph Schubart, Natalie Pelusi, Gernot Rohde, Tobias R. Overbeck, Jutta Kirfel, Jürgen Alt, Diego Kauffmann‐Guerrero, Frank Griesinger, Jonas Kulhavy, Michael Allgäuer, Anna Klimová, Maret Schütz, Daniela E. Aust, Maximilian J. Hochmair, Sacha I. Rothschild, Konstantinos N. Syrigos, Rajwanth Veluswamy, Sebastian Michels, Albrecht Stenzinger, Korinna Jöhrens, Martin Wermke
ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors
Ryo Kimura, Yuta Adachi, Kentaro Hirade, Satoru Kisoda, Shogo Yanase, Norio Shibata, Makoto Ishii, Yutaka Fujiwara, Rui Yamaguchi, Yasuko Fujita, Waki Hosoda, Hiromichi Ebi